# The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31

> **NCT07264283** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Adam Boxer** · enrollment: 147 (estimated)

## Conditions studied

- PSP - Progressive Supranuclear Palsy

## Interventions

- **DRUG:** LM11A-31
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT07264283
- **Lead sponsor:** Adam Boxer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2030-09-28
- **Final completion:** 2030-09-28
- **Target enrollment:** 147 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07264283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07264283, "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07264283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*